Table of Content - Endoprosthesis Market Size, Share Forecast 2032 | MRFR

Market Segmentation

Endoprosthesis Product Outlook (USD Billion, 2018-2032)

Knee

Shoulder

Elbow

Finger/Hand

Ankle/Foot

Endoprosthesis Knee Outlook (USD Billion, 2018-2032)

Primary

Partial

Revision Knee Replacement

Tumor

Custom Made

Endoprosthesis Hip Outlook (USD Billion, 2018-2032)

Primary

Partial

Revision Hip Replacement

Tumor

Custom Made

Endoprosthesis Shoulder Outlook (USD Billion, 2018-2032)

Primary

Revision Shoulder Replacement

Tumor

Custom Made

Endoprosthesis Elbow Outlook (USD Billion, 2018-2032)

Total Elbow

Radial Head Replacement

Tumor

Custom Made

Endoprosthesis Regional Outlook (USD Billion, 2018-2032)

North America Outlook (USD Billion, 2018-2032)
- North America Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- North America Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- North America Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- North America Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- North America Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- US Outlook (USD Billion, 2018-2032)
- US Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- US Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- US Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- US Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- US Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- CANADA Outlook (USD Billion, 2018-2032)
- CANADA Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- CANADA Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- CANADA Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- CANADA Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- CANADA Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made

Europe Outlook (USD Billion, 2018-2032)
- Europe Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Europe Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Europe Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Europe Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Europe Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- Germany Outlook (USD Billion, 2018-2032)
- Germany Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Germany Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Germany Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Germany Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Germany Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- France Outlook (USD Billion, 2018-2032)
- France Endoprosthesis by Product
  - Knee Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- France Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- France Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- France Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- France Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- UK Outlook (USD Billion, 2018-2032)
- UK Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- UK Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- UK Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- UK Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- UK Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- ITALY Outlook (USD Billion, 2018-2032)
- ITALY Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- ITALY Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- ITALY Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- ITALY Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- ITALY Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- SPAIN Outlook (USD Billion, 2018-2032)
- Spain Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Spain Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Spain Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Spain Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Spain Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- Rest Of Europe Outlook (USD Billion, 2018-2032)
- Rest Of Europe Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- REST OF EUROPE Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- REST OF EUROPE Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- REST OF EUROPE Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- REST OF EUROPE Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made

Asia-Pacific Outlook (USD Billion, 2018-2032)
- Asia-Pacific Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Asia-Pacific Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Asia-Pacific Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Asia-Pacific Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Asia-Pacific Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- China Outlook (USD Billion, 2018-2032)
- China Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- China Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- China Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- China Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- China Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- Japan Outlook (USD Billion, 2018-2032)
- Japan Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Japan Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Japan Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Japan Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Japan Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- India Outlook (USD Billion, 2018-2032)
- India Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- India Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- India Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- India Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- India Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- Australia Outlook (USD Billion, 2018-2032)
- Australia Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Australia Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Australia Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Australia Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Australia Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made
- Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
- Rest of Asia-Pacific Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Rest of Asia-Pacific Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Rest of Asia-Pacific Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Rest of Asia-Pacific Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Rest of Asia-Pacific Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made

Rest of the World Outlook (USD Billion, 2018-2032)
- Rest of the World Endoprosthesis by Product
  - Knee
  - Hip
  - Shoulder
  - Elbow
  - Finger/Hand
  - Ankle/Foot
- Rest of the World Endoprosthesis by Knee
  - Primary
  - Partial
  - Revision Knee Replacement
  - Tumor
  - Custom Made
- Rest of the World Endoprosthesis by Hip
  - Primary
  - Partial
  - Revision Hip Replacement
  - Tumor
  - Custom Made
- Rest of the World Endoprosthesis by Shoulder
  - Primary
  - Revision Shoulder Replacement
  - Tumor
  - Custom Made
- Rest of the World Endoprosthesis by Elbow
  - Total Elbow
  - Radial Head Replacement
  - Tumor
  - Custom Made

Middle East Outlook (USD Billion, 2018-2032)

Middle East Endoprosthesis by Product
- Knee
- Hip
- Shoulder
- Elbow
- Finger/Hand
- Ankle/Foot

Middle East Endoprosthesis by Knee
- Primary
- Partial
- Revision Knee Replacement
- Tumor
- Custom Made

Middle East Endoprosthesis by Hip
- Primary
- Partial
- Revision Hip Replacement
- Tumor
- Custom Made

Middle East Endoprosthesis by Shoulder
- Primary
- Revision Shoulder Replacement
- Tumor
- Custom Made

Middle East Endoprosthesis by Elbow
- Total Elbow
- Radial Head Replacement
- Tumor
- Custom Made

Africa Outlook (USD Billion, 2018-2032)

Africa Endoprosthesis by Product
- Knee
- Hip
- Shoulder
- Elbow
- Finger/Hand
- Ankle/Foot

Africa Endoprosthesis by Knee
- Primary
- Partial
- Revision Knee Replacement
- Tumor
- Custom Made

Africa Endoprosthesis by Hip
- Primary
- Partial
- Revision Hip Replacement
- Tumor
- Custom Made

Africa Endoprosthesis by Shoulder
- Primary
- Revision Shoulder Replacement
- Tumor
- Custom Made

Africa Endoprosthesis by Elbow
- Total Elbow
- Radial Head Replacement
- Tumor
- Custom Made

Latin America Outlook (USD Billion, 2018-2032)

Latin America Endoprosthesis by Product
- Knee
- Hip
- Shoulder
- Elbow
- Finger/Hand
- Ankle/Foot

Latin America Endoprosthesis by Knee
- Primary
- Partial
- Revision Knee Replacement
- Tumor
- Custom Made

Latin America Endoprosthesis by Hip
- Primary
- Partial
- Revision Hip Replacement
- Tumor
- Custom Made

Latin America Endoprosthesis by Shoulder
- Primary
- Revision Shoulder Replacement
- Tumor
- Custom Made

Latin America Endoprosthesis by Elbow
- Total Elbow
- Radial Head Replacement
- Tumor
- Custom Made

Research Methodology on Endoprosthesis Market

Introduction

Endoprosthesis is a type of medical device implant made of metal components, ceramic components, and polymers, inserted into the body to replace a missing joint or body part. Endoprosthesis offers an attractive alternative to traditional orthopaedic surgical methods and has recently become popular among medical practitioners due to its ability to restore function and improve quality of life. The global endoprosthesis market is set to experience healthy growth due to the large ageing population, increasing incidence of obesity-related conditions, increasing adoption of sports activities, and advances in healthcare technologies.

Research Methodology

A comprehensive research methodology for the market research report on the global endoprosthesis market has been employed to gain an in-depth understanding of the market. The primary and secondary sources of information used in the market research report include manufacturer data, industry reports, publications, news sources, government databases, and online research databases such as PubMed, LexisNexis, Google Scholar, etc.

1. Primary Research:

This includes research conducted with the help of interviews, surveys, focus groups, questionnaires, and user feedback. Primary research participants included professionals, end-users, and industry experts from the medical device industry who have an in-depth understanding of the endoprosthesis market.

In order to gain a better insight into the market, the respondents were asked questions such as:

-What are the major drivers for the growth of the global endoprosthesis market?

-What are the common challenges faced by the industry?

-What are the latest trends in the global endoprosthesis market?

-What are the emerging applications of endoprosthesis?

-What kind of new products have been developed in the past few years?

2. Secondary Research:

Secondary research was conducted to gain an in-depth understanding of the competitive landscape, regional market trends, and global economic conditions. The following sources of information were used:

-Industry reports from leading companies

-White papers from industry experts

-Government and trade association databases

-Financial reports

-Media and business journals

The secondary research was conducted to understand the past and present conditions of the market, to find out what the future trends in the market will be, and to map the market landscape of the global endoprosthesis market.

3. Market Size Estimation:

For estimating the market size of the global endoprosthesis market, two approaches were used - the top-down approach and the bottom-up approach. In the top-down approach, data from the key market players in the industry was gathered and the total market size was determined accordingly. While in the bottom-up approach, the total market size was estimated by adding up the revenues of all the segment players in the industry.

4. Data Triangulation:

Data triangulation was employed to capture the market trends and accurately represent the market size. The data collected through primary and secondary research was triangulated to obtain an accurate representation of the total global endoprosthesis market.

5. Market Breakdown & Data Verification:

In order to gain an in-depth understanding of the market, the data and information gathered through primary and secondary research were then validated through an in-depth analysis of the market trends in various regions. The report was then segmented based on the major product types, applications, technologies, end-users, and regions.

6. Modelling & Forecasting:

The report was then further modelled and forecasted to gain an understanding of the future growth prospects of the global endoprosthesis market. The market size estimations were created by using multiple sets of variables such as population growth rate, product price developments, changes in cost structure, market dynamics, technological advances, market-related risk factors, future product launches, and market share.

7. List of Participants:

The participants in the research report included end-users, medical device industry representatives, business solution providers, government and regulatory bodies, technology vendors, system integrators, technology providers, and other related players.

Conclusion

The research methodology employed in the market research report aims to provide an in-depth understanding of the global endoprosthesis market. A comprehensive primary and secondary research process was used to gather data from potential sources and verify the accuracy of the data. Market size estimation and forecasting were completed using both top-down and bottom-up approaches. Data triangulation and market breakdown were also used to obtain an accurate representation of the market.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF OSTEOARTHRITIS AMONG THE GERIATRIC POPULATION

4.2.2 INCREASED INCIDENCES OF BONE FRACTURES

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN ENDOPROSTHESIS DEVICES ENABLING EFFECTIVE TREATMENT

4.2.4 GROWING AWARENESS AMONG POPULATION

4.3 RESTRAINTS

4.3.1 ADVERSE EFFECTS ASSOCIATED WITH ENDOPROSTHESIS POST SURGERY

4.3.2 LACK OF HEALTHCARE INFRASTRUCTURE AND UNAFFORDABILITY IN EMERGING COUNTRIES

4.3.3 RESTRAINT IMPACT ANALYSIS

4.4 OPPORTUNITIES

4.4.1 RISING R&D INVESTMENTS FOR ENDOPROSTHESIS

4.4.2 INCREASING NUMBER OF PRODUCT LAUNCH, MERGER & ACQUISITION, AND EXPANSION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE ENDOPROSTHESIS MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON MARKET

5.3.4 DEMAND-SUPPLY GAP ANALYSIS

6 GLOBAL ENDOPROSTHESIS MARKET BY PRODUCT

6.1 OVERVIEW

6.2 KNEE

6.3 HIP

6.4 SHOULDER

6.5 ELBOW

6.6 FINGER/HAND

6.7 ANKLE/FOOT

7 GLOBAL ENDOPROSTHESIS MARKET BY KNEE

7.1 OVERVIEW

7.2 PRIMARY KNEE REPLACEMENT

7.2.1 PRIMARY CEMENTED KNEE REPLACEMENT

7.2.2 PRIMARY CEMENTLESS KNEE REPLACEMENT

7.2.3 PRIMARY HYBRID KNEE REPLACEMENT

7.2.4 BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT

7.2.4.1 PATELLA RESURFACING

7.2.4.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.2.4.3 UNCOATED KNEE REPLACEMENT

7.2.4.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.2.5 MOBILE-BEARING

7.2.6 FIXED-BEARING

7.2.6.1 FIXED-BEARING WITH CEMENTED STEM

7.2.6.2 OTHERS

7.2.7 POSTERIOR STABILIZED

7.2.8 CRUCIATE-RETAINING

7.2.8.1 ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING

7.2.8.2 LATERAL PIVOT

7.2.8.3 MEDIAL PIVOT

7.3 PARTIAL KNEE REPLACEMENT

7.3.1 UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT

7.3.2 BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT

7.3.3 PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT

7.3.3.1 PATELLA RESURFACING

7.3.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.3.3.3 UNCOATED KNEE REPLACEMENT

7.3.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.4 REVISION KNEE REPLACEMENT

7.4.1 COMPLETE NON-HINGED REVISION KNEE REPLACEMENT

7.4.2 COMPLETE HINGED REVISION KNEE REPLACEMENT

7.4.3 PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT

7.4.3.1 PATELLA RESURFACING

7.4.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.4.3.3 UNCOATED KNEE REPLACEMENT

7.4.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.4.3.5 DEFECT FILLER (METAPHYSEAL)

7.5 TUMOR

7.5.1 PROXIMAL TIBIA REPLACEMENT

7.5.2 DISTAL FEMUR REPLACEMENT

7.6 CUSTOM MADE REPLACEMENT

7.6.1 GROWING PROSTHESIS

8 GLOBAL ENDOPROSTHESIS MARKET BY HIP

8.1 OVERVIEW

8.2 PRIMARY HIP REPLACEMENT

8.2.1 PRIMARY CEMENTED HIP REPLACEMENT

8.2.2 PRIMARY CEMENTLESS HIP REPLACEMENT

8.2.3 PRIMARY HYBRID HIP REPLACEMENT

8.2.3.1 DUAL MOBILITY CUP CEMENTED

8.2.3.2 DUAL MOBILITY CUP CEMENTLESS

8.2.4 HIP RESURFACING

8.2.5 TOTAL HIP RESURFACING

8.2.6 HEMI HIP RESURFACING

8.3 PARTIAL HIP REPLACEMENT

8.3.1 BIPOLAR PARTIAL HIP REPLACEMENT

8.3.2 UNIPOLAR PARTIAL HIP REPLACEMENT

8.3.3 ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT

8.4 CUSTOM HIP REPLACEMENTS

8.5 REVISION HIP REPLACEMENT

8.5.1 COMPLETE HIP REVISION

8.5.1.1 COMPLETE HIP REVISION WITH DUAL MOBILITY CUP

8.5.2 ACETABULAR COMPONENT REVISION

8.5.2.1 ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP

8.5.3 FEMORAL STEM REVISION

8.5.4 OTHER HIP REVISION

8.6 TUMOR

8.6.1 PROXIMAL FEMUR REPLACEMENT

9 GLOBAL ENDOPROSTHESIS MARKET BY SHOULDER

9.1 OVERVIEW

9.2 PRIMARY SHOULDER REPLACEMENT

9.2.1 PARTIAL SHOULDER REPLACEMENT

9.2.2 TOTAL/PRIMARY SHOULDER REPLACEMENT

9.2.3 REVERSE SHOULDER REPLACEMENT

9.2.4 SHOULDER RESURFACING

9.3 REVISION SHOULDER REPLACEMENTS

9.4 TUMOR

9.4.1 PROXIMAL HUMERUS REPLACEMENT

9.5 CUSTOM MADE REPLACEMENTS

10 GLOBAL ENDOPROSTHESIS MARKET BY ELBOW

10.1 OVERVIEW

10.2 TOTAL ELBOW REPLACEMENT

10.3 RADIAL HEAD REPLACEMENT

10.4 TUMOR

10.4.1 PROXIMAL ULNA REPLACEMENT

10.4.2 DISTAL HUMERUS REPLACEMENT

10.5 CUSTOM MADE REPLACEMENTS

11 GLOBAL ENDOPROSTHESIS MARKET BY FINGER/HAND

11.1 OVERVIEW

11.2 TOTAL WRIST PROTHESIS

11.3 PIP FINGER PROSTHESIS

11.4 MCP FINGER PROSTHESIS

11.4.1 CARPOMETACARPAL JOINT PROSTHESIS

11.4.2 OTHERS

12 GLOBAL ENDOPROSTHESIS MARKET BY ANKLE/FOOT

12.1 OVERVIEW

12.2 TOTAL ANKLE

12.3 GREAT TOE IMPLANT

13 GLOBAL ENDOPROSTHESIS MARKET, BY REGION

13.1 OVERVIEW

13.2 NORTH AMERICA

13.2.1 US

13.2.2 CANADA

13.2.3 MEXICO

13.3 SOUTH AMERICA

13.3.1 ARGENTINA

13.3.2 BRAZIL

13.3.3 COLOMBIA

13.3.4 PERU

13.3.5 CHILE

13.3.6 ECUADOR

13.3.7 REST OF SOUTH AMERICA

13.4 EUROPE

13.4.1 GERMANY

13.4.2 AUSTRIA

13.4.3 SWISS

13.4.4 FINLAND

13.4.5 DENMARK

13.4.6 NORWAY

13.4.7 SWEDEN

13.4.8 BELGIUM

13.4.9 FRANCE

13.4.10 NETHERLANDS

13.4.11 GREAT BRITAIN

13.4.12 CZECHIA

13.4.13 ITALIA

13.4.14 SPAIN

13.4.15 HUNGARY

13.4.16 IRELAND

13.4.17 PORTUGAL

13.4.18 POLAND

13.4.19 RUSSIA

13.4.20 ROMANIA

13.4.21 TURKEY

13.4.22 REST OF EUROPE

13.5 ASIA-PACIFIC

13.5.1 CHINA

13.5.2 JAPAN

13.5.3 INDIA

13.5.4 AUSTRALIA

13.5.5 SOUTH KOREA

13.5.6 TAIWAN

13.5.7 NEW ZEALAND

13.5.8 REST OF ASIA-PACIFIC

13.6 MIDDLE EAST & AFRICA

13.6.1 SAUDI ARABIA

13.6.2 UAE

13.6.3 EGYPT

13.6.4 ISRAEL

13.6.5 SOUTH AFRICA

13.6.6 SYRIA

13.6.7 REST OF MEA

14 COMPETITIVE LANDSCAPE

14.1 COMPETITIVEOVERVIEW

14.2 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

14.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ENDOPROSTHESIS MARKET

14.4 COMPETITIVE BENCHMARKING

14.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ENDOPROSTHESIS MARKET

14.6 KEY DEVELOPMENT ANALYSIS

14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

14.7.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

14.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES

14.8 MAJOR PLAYERS FINANCIAL MATRIX

14.8.1 REVENUE OF MAJOR PLAYERS

14.8.2 R&D EXPENDITURE

15 COMPANY PROFILES

15.1 JOHNSON & JOHNSON SERVICES, INC.

15.1.1 COMPANY OVERVIEW

15.1.2 FINANCIAL OVERVIEW

15.1.3 PRODUCTS/SERVICES OFFERED

15.1.4 KEY DEVELOPMENTS

15.1.5 SWOT ANALYSIS

15.1.6 KEY STRATEGIES

15.2 ZIMMER BIOMET HOLDINGS INC.

15.2.1 COMPANY OVERVIEWS

15.2.2 FINANCIAL OVERVIEW

15.2.3 PRODUCTS/SERVICES OFFERED

15.2.4 KEY DEVELOPMENTS

15.2.5 SWOT ANALYSIS

15.2.6 KEY STRATEGIES

15.3 STRYKER

15.3.1 COMPANY OVERVIEW

15.3.2 FINANCIAL OVERVIEW

15.3.3 PRODUCTS/SERVICES OFFERED

15.3.4 KEY DEVELOPMENTS

15.3.5 SWOT ANALYSIS

15.3.6 KEY STRATEGIES

15.4 SMITH AND NEPHEW

15.4.1 COMPANY OVERVIEW

15.4.2 FINANCIAL OVERVIEW

15.4.3 PRODUCTS/SERVICES OFFERED

15.4.4 KEY DEVELOPMENTS

15.4.5 SWOT ANALYSIS

15.4.6 KEY STRATEGIES

15.5 WALDEMAR LINK GMBH & CO. KG

15.5.1 COMPANY OVERVIEW

15.5.2 FINANCIAL OVERVIEW

15.5.3 PRODUCTS/SERVICES OFFERED

15.5.4 KEY DEVELOPMENTS

15.5.5 SWOT ANALYSIS

15.5.6 KEY STRATEGIES

15.6 LIMACORPORATE SPA.

15.6.1 COMPANY OVERVIEW

15.6.2 FINANCIAL OVERVIEW

15.6.3 PRODUCTS/SERVICES OFFERED

15.6.4 KEY DEVELOPMENTS

15.6.5 SWOT ANALYSIS

15.6.6 KEY STRATEGIES

15.7 CORIN LTD

15.7.1 COMPANY OVERVIEW

15.7.2 FINANCIAL OVERVIEW

15.7.3 PRODUCTS OFFERED

15.7.4 KEY DEVELOPMENTS

15.7.5 SWOT ANALYSIS

15.7.6 KEY STRATEGIES

15.8 PETER BREHM GMBH

15.8.1 COMPANY OVERVIEW

15.8.2 FINANCIAL OVERVIEW

15.8.3 PRODUCTS OFFERED

15.8.4 KEY DEVELOPMENTS

15.8.5 SWOT ANALYSIS

15.8.6 KEY STRATEGIES

15.9 MATHYS LTD BETTLACH

15.9.1 COMPANY OVERVIEW

15.9.2 FINANCIAL OVERVIEW

15.9.3 PRODUCTS OFFERED

15.9.4 KEY DEVELOPMENTS

15.9.5 SWOT ANALYSIS

15.9.6 KEY STRATEGIES

15.10 B. BRAUN MELSUNGEN AG

15.10.1 COMPANY OVERVIEW

15.10.2 FINANCIAL OVERVIEW

15.10.3 PRODUCTS OFFERED

15.10.4 KEY DEVELOPMENTS

15.10.5 SWOT ANALYSIS

15.10.6 KEY STRATEGIES

15.11 MEDACTA INTERNATIONAL SA

15.11.1 COMPANY OVERVIEW

15.11.2 FINANCIAL OVERVIEW

15.11.3 PRODUCTS/SERVICES OFFERED

15.11.4 KEY DEVELOPMENTS

15.11.5 SWOT ANALYSIS

15.11.6 KEY STRATEGIES

15.12 EXACTECH, INC.

15.12.1 COMPANY OVERVIEW

15.12.2 FINANCIAL OVERVIEW

15.12.3 PRODUCTS OFFERED

15.12.4 KEY DEVELOPMENTS

15.12.5 SWOT ANALYSIS

15.12.6 KEY STRATEGIES

15.13 MICROPORT ORTHOPEDICS, INC.

15.13.1 COMPANY OVERVIEW

15.13.2 FINANCIAL OVERVIEW

15.13.3 PRODUCTS OFFERED

15.13.4 KEY DEVELOPMENTS

15.13.5 SWOT ANALYSIS

15.13.6 KEY STRATEGIES

15.14 TIPSAN

15.14.1 COMPANY OVERVIEW

15.14.2 FINANCIAL OVERVIEW

15.14.3 PRODUCTS OFFERED

15.14.4 KEY DEVELOPMENTS

15.14.5 SWOT ANALYSIS

15.14.6 KEY STRATEGIES

15.15 BAUMER SA.

15.15.1 COMPANY OVERVIEW

15.15.2 FINANCIAL OVERVIEW

15.15.3 PRODUCTS OFFERED

15.15.4 KEY DEVELOPMENTS

15.15.5 SWOT ANALYSIS

15.15.6 KEY STRATEGIES

15.16 IMPOL

15.16.1 COMPANY OVERVIEW

15.16.2 FINANCIAL OVERVIEW

15.16.3 PRODUCTS OFFERED

15.16.4 KEY DEVELOPMENTS

15.16.5 SWOT ANALYSIS

15.16.6 KEY STRATEGIES

15.17 GROUPE LEPINE

15.17.1 COMPANY OVERVIEW

15.17.2 FINANCIAL OVERVIEW

15.17.3 PRODUCTS OFFERED

15.17.4 KEY DEVELOPMENTS

15.17.5 SWOT ANALYSIS

15.17.6 KEY STRATEGIES

15.18 CONFORMIS

15.18.1 COMPANY OVERVIEW

15.18.2 FINANCIAL OVERVIEW

15.18.3 PRODUCTS OFFERED

15.18.4 KEY DEVELOPMENTS

15.18.5 SWOT ANALYSIS

15.18.6 KEY STRATEGIES

15.19 DJO

15.19.1 COMPANY OVERVIEW

15.19.2 FINANCIAL OVERVIEW

15.19.3 PRODUCTS OFFERED

15.19.4 KEY DEVELOPMENTS

15.19.5 SWOT ANALYSIS

15.19.6 KEY STRATEGIES

15.20 IMPLANTCAST

15.20.1 COMPANY OVERVIEW

15.20.2 FINANCIAL OVERVIEW

15.20.3 PRODUCTS OFFERED

15.20.4 KEY DEVELOPMENTS

15.20.5 SWOT ANALYSIS

15.20.6 KEY STRATEGIES

16 APPENDIX

16.1 REFERENCES

16.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 4 GLOBAL: ENDOPROSTHESIS MARKET, BY KNEE, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 6 GLOBAL: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 7 GLOBAL: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 8 GLOBAL: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 9 GLOBAL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 10 GLOBAL: ENDOPROSTHESIS MARKET, BY KNEE TYPE, 2022-2030 (USD MILLION)

TABLE 11 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 12 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY TYPE 2022–2030 (USD MILLION)

TABLE 13 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 14 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTLESS KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 15 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 16 GLOBAL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 17 GLOBAL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 18 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 19 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 20 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 21 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2022–2030 (USD MILLION)

TABLE 22 GLOBAL: ENDOPROSTHESIS MARKET, FOR MOBILE-BEARING, BY REGION, 2022–2030 (USD MILLION)

TABLE 23 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY REGION, 2022–2030 (USD MILLION)

TABLE 24 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022–2030 (USD MILLION)

TABLE 25 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING WITH CEMENTED STEM, BY REGION, 2022–2030 (USD MILLION)

TABLE 26 GLOBAL: ENDOPROSTHESIS MARKET, BY OTHERS, BY REGION, 2022–2030 (USD MILLION)

TABLE 27 GLOBAL: ENDOPROSTHESIS MARKET, FOR POSTERIOR STABILIZED, BY REGION, 2022–2030 (USD MILLION)

TABLE 28 GLOBAL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY REGION, 2022–2030 (USD MILLION)

TABLE 29 GLOBAL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022–2030 (USD MILLION)

TABLE 30 GLOBAL: ENDOPROSTHESIS MARKET, FOR ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING, BY REGION, 2022–2030 (USD MILLION)

TABLE 31 GLOBAL: ENDOPROSTHESIS MARKET, FOR LATERAL PIVOT, BY REGION, 2022–2030 (USD MILLION)

TABLE 32 GLOBAL: ENDOPROSTHESIS MARKET, FOR MEDIALPIVOT, BY REGION, 2022–2030 (USD MILLION)

TABLE 33 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 34 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY TYPE 2022–2030 (USD MILLION)

TABLE 35 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 36 GLOBAL: ENDOPROSTHESIS MARKET, FOR BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 37 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 38 GLOBAL: ENDOPROSTHESIS MARKET, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 39 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 40 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 41 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 42 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2022–2030 (USD MILLION)

TABLE 43 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 44 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 45 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE NON-HINGED REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 46 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HINGED REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 47 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 48 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 49 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 50 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 51 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 52 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2022–2030 (USD MILLION)

TABLE 53 GLOBAL: ENDOPROSTHESIS MARKET, FOR DEFECT FILLER (METAPHYSEAL), BY REGION, 2022–2030 (USD MILLION)

TABLE 54 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)

TABLE 55 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022–2030 (USD MILLION)

TABLE 56 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL TIBIA REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 57 GLOBAL: ENDOPROSTHESIS MARKET, FOR DISTAL FEMUR REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 58 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 59 GLOBAL: ENDOPROSTHESIS MARKET, FOR GROWING PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)

TABLE 60 GLOBAL: ENDOPROSTHESIS MARKET, BY HIP TYPE, 2022-2030 (USD MILLION)

TABLE 61 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 62 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 63 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTED HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 64 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTLESS HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 65 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 66 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 67 GLOBAL: ENDOPROSTHESIS MARKET, FOR DUAL MOBILITY CUP CEMENTED, BY REGION, 2022–2030 (USD MILLION)

TABLE 68 GLOBAL: ENDOPROSTHESIS MARKET, FOR DUAL MOBILITY CUP CEMENTLESS, BY REGION, 2022–2030 (USD MILLION)

TABLE 69 GLOBAL: ENDOPROSTHESIS MARKET, FOR HIP RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 70 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL HIP RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 71 GLOBAL: ENDOPROSTHESIS MARKET, FOR HEMI HIP RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 72 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 73 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 74 GLOBAL: ENDOPROSTHESIS MARKET, FOR BIPOLAR PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 75 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNIPOLAR PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 76 GLOBAL: ENDOPROSTHESIS MARKET, FOR ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 77 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM HIP REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)

TABLE 78 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 79 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 80 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 81 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION WITH DUAL MOBILITY CUP, BY REGION, 2022–2030 (USD MILLION)

TABLE 82 GLOBAL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, BY REGION, 2022–2030 (USD MILLION)

TABLE 83 GLOBAL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP, BY REGION, 2022–2030 (USD MILLION)

TABLE 84 GLOBAL: ENDOPROSTHESIS MARKET, FOR FEMORAL STEM REVISION, BY REGION, 2022–2030 (USD MILLION)

TABLE 85 GLOBAL: ENDOPROSTHESIS MARKET, FOR OTHER HIP REVISION, BY REGION, 2022–2030 (USD MILLION)

TABLE 86 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)

TABLE 87 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL FEMUR REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 88 GLOBAL: ENDOPROSTHESIS MARKET, BY SHOULDER TYPE, 2022-2030 (USD MILLION)

TABLE 89 GLOBAL: ENDOPROSTHESIS MARKET, BY PRIMARY SHOULDER REPLACEMENT, 2022–2030 (USD MILLION)

TABLE 90 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)

TABLE 91 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL SHOULDER REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 92 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL/PRIMARY SHOULDER REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 93 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVERSE SHOULDER REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 94 GLOBAL: ENDOPROSTHESIS MARKET, FOR SHOULDER RESURFACING, BY REGION, 2022–2030 (USD MILLION)

TABLE 95 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION SHOULDER REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)

TABLE 96 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)

TABLE 97 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022–2030 (USD MILLION)

TABLE 98 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL HUMERUS REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 99 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)

TABLE 100 GLOBAL: ENDOPROSTHESIS MARKET, BY ELBOW TYPE, 2022-2030 (USD MILLION)

TABLE 101 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL ELBOW REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 102 GLOBAL: ENDOPROSTHESIS MARKET, FOR RADIAL HEAD REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 103 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)

TABLE 104 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022–2030 (USD MILLION)

TABLE 105 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL ULNA REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 106 GLOBAL: ENDOPROSTHESIS MARKET, FOR DISTAL HUMERUS REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)

TABLE 107 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)

TABLE 108 GLOBAL: ENDOPROSTHESIS MARKET, BY FINGER/HAND TYPE, 2022-2030 (USD MILLION)

TABLE 109 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL WRIST PROTHESIS, BY REGION, 2022–2030 (USD MILLION)

TABLE 110 GLOBAL: ENDOPROSTHESIS MARKET, FOR PIP FINGER PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)

TABLE 111 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)

TABLE 112 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY TYPE, 2022–2030 (USD MILLION)

TABLE 113 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)

TABLE 114 GLOBAL: ENDOPROSTHESIS MARKET, FOR OTHERS, BY REGION, 2022–2030 (USD MILLION)

TABLE 115 GLOBAL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT TYPE, 2022-2030 (USD MILLION)

TABLE 116 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL ANKLE, BY REGION, 2022–2030 (USD MILLION)

TABLE 117 GLOBAL: ENDOPROSTHESIS MARKET, FOR GREAT TOE IMPLANT, BY REGION, 2022–2030 (USD MILLION)

TABLE 118 GLOBAL: ENDOPROSTHESIS MARKET, BY REGION, 2022–2030 (USD MILLION)

TABLE 119 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)

TABLE 120 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 121 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRODUCT, BY KNEE, 2022-2030 (USD MILLION)

TABLE 122 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 123 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 124 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 125 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 126 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 127 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 128 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 129 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 130 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022-2030 (USD MILLION)

TABLE 131 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY TYPE, 2022-2030 (USD MILLION)

TABLE 132 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 133 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 134 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 135 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 136 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 137 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 138 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 139 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 140 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 141 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 142 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 143 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 144 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 145 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 146 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 147 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 148 US: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 149 US: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 150 US: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 151 US: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 152 US: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 153 US: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 154 US: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 155 US: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 156 US: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 157 US: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 158 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 159 US: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 160 US: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 161 US: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 162 US: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 163 US: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 164 US: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 165 US: ENDOPROSTHESIS MARKET, COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 166 US: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 167 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 168 US: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 169 US: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 170 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 171 US: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 172 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 173 US: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 174 US: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 175 US: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 176 CANADA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 177 CANADA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 178 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 179 CANADA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 180 CANADA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 181 CANADA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 182 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 183 CANADA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 184 CANADA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 185 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 186 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 187 CANADA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 188 CANADA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 189 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 190 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 191 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 192 CANADA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 193 CANADA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 194 CANADA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 195 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 196 CANADA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 197 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 198 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 199 CANADA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 200 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 201 CANADA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 202 CANADA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 203 CANADA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 204 MEXICO: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 205 MEXICO: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 206 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 207 MEXICO: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 208 MEXICO: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 209 MEXICO: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 210 MEXICO: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 211 MEXICO: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 212 MEXICO: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 213 MEXICO: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 214 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 215 MEXICO: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 216 MEXICO: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 217 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 218 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 219 MEXICO: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 220 MEXICO: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 221 MEXICO: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 222 MEXICO: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 223 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 224 MEXICO: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 225 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 226 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 227 MEXICO: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 228 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 229 MEXICO: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 230 MEXICO: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 231 MEXICO: ENDOPROSTHESIS MARKET, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 232 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)

TABLE 233 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 234 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 235 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 236 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 237 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 238 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 239 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 240 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 241 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 242 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 243 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 244 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 245 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 246 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 247 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 248 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 249 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 250 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 251 SOUTH AMERICA: ENDOPROSTHESIS MARKET, ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 252 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 253 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 254 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 255 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 256 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 257 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 258 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 259 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 260 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 261 ARGENTINA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 262 ARGENTINA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 263 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 264 ARGENTINA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 265 ARGENTINA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 266 ARGENTINA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 267 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 268 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 269 ARGENTINA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 270 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 271 ARGENTINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 272 ARGENTINA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 273 ARGENTINA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 274 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 275 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 276 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 277 ARGENTINA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 278 ARGENTINA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 279 ARGENTINA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 280 ARGENTINA: ENDOPROSTHESIS MARKET, TUMOR, 2022-2030 (USD MILLION)

TABLE 281 ARGENTINA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 282 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 283 ARGENTINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 284 ARGENTINA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 285 ARGENTINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 286 ARGENTINA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 287 ARGENTINA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 288 ARGENTINA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 289 BRAZIL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 290 BRAZIL: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 291 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 292 BRAZIL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 293 BRAZIL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 294 BRAZIL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 295 BRAZIL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 296 BRAZIL: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 297 BRAZIL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 298 BRAZIL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 299 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 300 BRAZIL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 301 BRAZIL: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 302 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 303 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 304 BRAZIL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 305 BRAZIL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 306 BRAZIL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 307 BRAZIL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 308 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 309 BRAZIL: ENDOPROSTHESIS MARKET, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 310 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 311 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 312 BRAZIL: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 313 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 314 BRAZIL: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 315 BRAZIL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 316 BRAZIL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 317 COLOMBIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 318 COLOMBIA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 319 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 320 COLOMBIA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 321 COLOMBIA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 322 COLOMBIA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 323 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 324 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 325 COLOMBIA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 326 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 327 COLOMBIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 328 COLOMBIA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 329 COLOMBIA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 330 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 331 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 332 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 333 COLOMBIA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 334 COLOMBIA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 335 COLOMBIA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 336 COLOMBIA: ENDOPROSTHESIS MARKET, TUMOR, 2022-2030 (USD MILLION)

TABLE 337 COLOMBIA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 338 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 339 COLOMBIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 340 COLOMBIA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 341 COLOMBIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 342 COLOMBIA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 343 COLOMBIA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 344 COLOMBIA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 345 PERU: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 346 PERU: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 347 PERU: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 348 PERU: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 349 PERU: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 350 PERU: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 351 PERU: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 352 PERU: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 353 PERU: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 354 PERU: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 355 PERU: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 356 PERU: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 357 PERU: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 358 PERU: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 359 PERU: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 360 PERU: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 361 PERU: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 362 PERU: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 363 PERU: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 364 PERU: ENDOPROSTHESIS MARKET, TUMOR, 2022-2030 (USD MILLION)

TABLE 365 PERU: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 366 PERU: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 367 PERU: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 368 PERU: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 369 PERU: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 370 PERU: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 371 PERU: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 372 PERU: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 373 CHILE: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 374 CHILE: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 375 CHILE: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 376 CHILE: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 377 CHILE: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 378 CHILE: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 379 CHILE: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 380 CHILE: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 381 CHILE: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 382 CHILE: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 383 CHILE: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 384 CHILE: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 385 CHILE: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 386 CHILE: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 387 CHILE: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 388 CHILE: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 389 CHILE: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 390 CHILE: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 391 CHILE: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 392 CHILE: ENDOPROSTHESIS MARKET, TUMOR, 2022-2030 (USD MILLION)

TABLE 393 CHILE: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 394 CHILE: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 395 CHILE: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 396 CHILE: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 397 CHILE: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 398 CHILE: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 399 CHILE: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 400 CHILE: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 401 ECUADOR: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 402 ECUADOR: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 403 ECUADOR: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 404 ECUADOR: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 405 ECUADOR: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 406 ECUADOR: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 407 ECUADOR: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 408 ECUADOR: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 409 ECUADOR: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 410 ECUADOR: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 411 ECUADOR: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 412 ECUADOR: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 413 ECUADOR: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 414 ECUADOR: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 415 ECUADOR: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 416 ECUADOR: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 417 ECUADOR: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 418 ECUADOR: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 419 ECUADOR: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 420 ECUADOR: ENDOPROSTHESIS MARKET, TUMOR, 2022-2030 (USD MILLION)

TABLE 421 ECUADOR: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 422 ECUADOR: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 423 ECUADOR: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 424 ECUADOR: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 425 ECUADOR: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 426 ECUADOR: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 427 ECUADOR: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 428 ECUADOR: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 429 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 430 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 431 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 432 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 433 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 434 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 435 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 436 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 437 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 438 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 439 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 440 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 441 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 442 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 443 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 444 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 445 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 446 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 447 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 448 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, TUMOR, 2022-2030 (USD MILLION)

TABLE 449 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 450 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 451 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 452 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 453 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 454 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 455 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 456 REST OF SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 457 EUROPE: ENDOPROSTHESIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)

TABLE 458 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 459 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 460 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 461 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 462 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 463 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 464 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 465 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 466 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 467 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 468 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 469 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 470 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 471 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 472 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 473 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 474 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 475 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 476 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 477 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 478 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 479 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 480 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 481 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 482 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 483 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 484 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 485 EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 486 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 487 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 488 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 489 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 490 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 491 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 492 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 493 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 494 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 495 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 496 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 497 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 498 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 499 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 500 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 501 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 502 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 503 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 504 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 505 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 506 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 507 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 508 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 509 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 510 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 511 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 512 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 513 GERMANY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 514 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 515 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 516 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 517 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 518 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 519 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 520 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 521 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 522 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 523 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 524 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 525 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 526 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 527 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 528 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 529 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 530 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 531 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 532 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 533 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 534 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 535 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 536 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 537 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 538 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 539 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 540 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 541 AUSTRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 542 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 543 SWISS ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 544 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 545 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 546 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 547 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 548 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 549 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 550 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 551 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 552 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 553 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 554 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 555 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 556 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 557 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 558 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 559 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 560 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 561 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 562 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 563 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 564 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 565 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 566 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 567 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 568 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 569 SWISS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 570 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 571 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 572 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 573 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 574 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 575 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 576 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 577 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 578 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 579 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 580 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 581 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 582 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 583 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 584 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 585 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 586 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 587 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 588 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 589 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 590 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 591 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 592 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 593 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 594 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 595 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 596 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 597 FINLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 598 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 599 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 600 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 601 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 602 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 603 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 604 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 605 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 606 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 607 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 608 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 609 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 610 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 611 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 612 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 613 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 614 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 615 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 616 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 617 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 618 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 619 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 620 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 621 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 622 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 623 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 624 DENMARK: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 625 DENMARK ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 626 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 627 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 628 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 629 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 630 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 631 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 632 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 633 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 634 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 635 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 636 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 637 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 638 NORWAY ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 639 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 640 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 641 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 642 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 643 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 644 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 645 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 646 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 647 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 648 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 649 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 650 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 651 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 652 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 653 NORWAY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 654 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 655 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 656 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 657 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 658 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 659 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 660 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 661 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 662 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 663 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 664 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 665 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 666 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 667 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 668 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 669 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 670 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 671 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 672 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 673 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 674 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 675 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 676 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 677 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 678 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 679 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 680 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 681 SWEDEN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 682 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 683 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 684 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 685 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 686 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 687 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 688 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 689 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 690 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 691 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 692 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 693 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 694 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 695 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 696 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 697 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 698 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 699 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 700 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 701 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 702 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 703 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 704 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 705 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 706 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 707 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 708 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 709 BELGIUM: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 710 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 711 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 712 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 713 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 714 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 715 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 716 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 717 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 718 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 719 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 720 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 721 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 722 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 723 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 724 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 725 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 726 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 727 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 728 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 729 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 730 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 731 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 732 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 733 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 734 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 735 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 736 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 737 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 738 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 739 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 740 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 741 FRANCE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 742 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 743 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 744 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 745 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 746 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 747 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 748 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 749 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 750 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 751 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 752 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 753 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 754 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 755 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 756 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 757 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 758 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 759 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 760 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 761 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 762 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 763 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 764 NETHERLANDS: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 765 NETHERLANDS ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 766 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 767 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 768 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 769 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 770 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 771 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 772 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 773 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 774 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 775 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 776 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 777 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 778 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 779 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 780 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 781 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 782 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 783 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 784 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 785 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 786 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 787 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 788 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 789 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 790 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 791 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 792 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 793 GREAT BRITAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 794 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 795 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 796 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 797 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 798 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 799 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 800 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 801 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 802 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 803 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 804 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 805 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 806 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 807 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 808 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 809 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 810 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 811 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 812 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 813 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 814 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 815 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 816 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 817 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 818 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 819 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 820 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 821 CZECHIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 822 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 823 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 824 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 825 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 826 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 827 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 828 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 829 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 830 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 831 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 832 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 833 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 834 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 835 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 836 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 837 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 838 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 839 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 840 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 841 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 842 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 843 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 844 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 845 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 846 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 847 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 848 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 849 ITALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 850 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 851 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 852 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 853 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 854 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 855 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 856 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 857 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 858 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 859 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 860 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 861 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 862 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 863 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 864 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 865 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 866 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 867 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 868 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 869 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 870 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 871 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 872 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 873 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 874 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 875 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 876 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 877 SPAIN: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 878 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 879 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 880 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 881 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 882 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 883 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 884 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 885 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 886 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 887 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 888 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 889 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 890 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 891 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 892 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 893 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 894 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 895 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 896 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 897 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 898 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 899 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 900 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 901 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 902 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 903 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 904 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 905 HUNGARY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 906 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 907 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 908 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 909 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 910 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 911 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 912 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 913 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 914 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 915 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 916 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 917 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 918 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 919 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 920 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 921 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 922 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 923 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 924 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 925 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 926 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 927 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 928 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 929 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 930 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 931 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 932 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 933 IRELAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 934 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 935 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 936 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 937 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 938 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 939 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 940 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 941 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 942 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 943 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 944 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 945 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 946 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 947 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 948 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 949 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 950 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 951 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 952 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 953 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 954 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 955 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 956 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 957 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 958 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 959 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 960 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 961 PORTUGAL: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 962 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 963 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 964 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 965 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 966 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 967 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 968 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 969 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 970 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 971 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 972 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 973 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 974 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 975 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 976 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 977 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 978 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 979 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 980 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 981 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 982 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 983 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 984 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 985 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 986 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 987 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 988 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 989 POLAND: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 990 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 991 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 992 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 993 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 994 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 995 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 996 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 997 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 998 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 999 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1000 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1001 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1002 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 1003 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1004 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1005 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1006 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1007 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1008 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 1009 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1010 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 1011 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1012 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1013 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 1014 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 1015 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1016 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1017 RUSSIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1018 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1019 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 1020 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 1021 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1022 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 1023 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 1024 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1025 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1026 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1027 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1028 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1029 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1030 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 1031 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1032 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1033 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1034 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1035 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1036 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 1037 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1038 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 1039 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1040 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1041 ROMANIA ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 1042 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 1043 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1044 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1045 ROMANIA: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1046 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1047 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 1048 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 1049 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1050 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 1051 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 1052 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1053 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1054 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1055 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1056 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1057 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1058 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 1059 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1060 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1061 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1062 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1063 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1064 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 1065 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1066 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 1067 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1068 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1069 TURKEY ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 1070 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 1071 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1072 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1073 TURKEY: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1074 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1075 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, 2022-2030 (USD MILLION)

TABLE 1076 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PRIMARY KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 1077 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY BCR KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1078 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY FIXED BEARING, 2022-2030 (USD MILLION)

TABLE 1079 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR PRIMARY KNEE REPLACEMENT, BY CRUCIATE-RETAINING, 2022-2030 (USD MILLION)

TABLE 1080 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1081 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR KNEE, BY PARTIAL KNEE REPLACEMENT, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1082 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1083 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR REVISION KNEE REPLACEMENT, BY PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1084 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1085 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR CUSTOM MADE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1086 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, 2022-2030 (USD MILLION)

TABLE 1087 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1088 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PRIMARY HIP REPLACEMENT, BY PRIMARY HYBRID HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1089 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1090 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1091 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1092 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY REVISION HIP REPLACEMENT, BY ACETABULAR COMPONENT, 2022-2030 (USD MILLION)

TABLE 1093 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR HIP, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1094 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, 2022-2030 (USD MILLION)

TABLE 1095 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1096 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR SHOULDER, BY TUMOR, 2022-2030 (USD MILLION)

TABLE 1097 REST OF EUROPE ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, 2022-2030 (USD MILLION)

TABLE 1098 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ELBOW, BY TUMOR 2022-2030 (USD MILLION)

TABLE 1099 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1100 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR FINGER/HAND, BY MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1101 REST OF EUROPE: ENDOPROSTHESIS MARKET, BY PRODUCT, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1102 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)

TABLE 1103 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1104 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1105 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT BY TYPE, 2022-2030 (USD MILLION)

TABLE 1106 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1107 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1108 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1109 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1110 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1111 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1112 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1113 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1114 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1115 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1116 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1117 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1118 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1119 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1120 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1121 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1122 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1123 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1124 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1125 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1126 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1127 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1128 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1129 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1130 ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1131 CHINA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1132 CHINA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1133 CHINA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1134 CHINA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1135 CHINA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1136 CHINA ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1137 CHINA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1138 CHINA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1139 CHINA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1140 CHINA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1141 CHINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1142 CHINA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1143 CHINA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1144 CHINA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1145 CHINA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1146 CHINA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1147 CHINA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1148 CHINA: ENDOPROSTHESIS MARKET, COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1149 CHINA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1150 CHINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1151 CHINA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1152 CHINA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1153 CHINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1154 CHINA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1155 CHINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1156 CHINA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1157 CHINA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1158 CHINA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1159 JAPAN: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1160 JAPAN: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1161 JAPAN: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1162 JAPAN: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1163 JAPAN: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1164 JAPAN: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1165 JAPAN: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1166 JAPAN: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1167 JAPAN: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1168 JAPAN: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1169 JAPAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1170 JAPAN: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1171 JAPAN: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1172 JAPAN: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1173 JAPAN: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1174 JAPAN: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1175 JAPAN: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1176 JAPAN: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1177 JAPAN: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1178 JAPAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1179 JAPAN: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1180 JAPAN: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1181 JAPAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1182 JAPAN: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1183 JAPAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1184 JAPAN: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1185 JAPAN: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1186 JAPAN: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1187 INDIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1188 INDIA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1189 INDIA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1190 INDIA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1191 INDIA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1192 INDIA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1193 INDIA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1194 INDIA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1195 INDIA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1196 INDIA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 1197 INDIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1198 INDIA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1199 INDIA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1200 INDIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1201 INDIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1202 INDIA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1203 INDIA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1204 INDIA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1205 INDIA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1206 INDIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1207 INDIA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1208 INDIA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1209 INDIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1210 INDIA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1211 INDIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1212 INDIA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1213 INDIA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1214 INDIA: ENDOPROSTHESIS MARKET, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1215 AUSTRALIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1216 AUSTRALIA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1217 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1218 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1219 AUSTRALIA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1220 AUSTRALIA ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1221 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1222 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1223 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1224 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1225 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1226 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1227 AUSTRALIA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1228 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1229 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1230 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1231 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1232 AUSTRALIA: ENDOPROSTHESIS MARKET, COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1233 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1234 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1235 AUSTRALIA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1236 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1237 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1238 AUSTRALIA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1239 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1240 AUSTRALIA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1241 AUSTRALIA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1242 AUSTRALIA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1243 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1244 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1245 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1246 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1247 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1248 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1249 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1250 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1251 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1252 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1253 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1254 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1255 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1256 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1257 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1258 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1259 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1260 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1261 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1262 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1263 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1264 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1265 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1266 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1267 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1268 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1269 SOUTH KOREA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1270 SOUTH KOREA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1271 TAIWAN: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1272 TAIWAN: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1273 TAIWAN: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1274 TAIWAN: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1275 TAIWAN: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1276 TAIWAN: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1277 TAIWAN: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1278 TAIWAN: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1279 TAIWAN: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1280 TAIWAN: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 1281 TAIWAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1282 TAIWAN: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1283 TAIWAN: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1284 TAIWAN: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1285 TAIWAN: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1286 TAIWAN: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1287 TAIWAN: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1288 TAIWAN: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1289 TAIWAN: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1290 TAIWAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1291 TAIWAN: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1292 TAIWAN: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1293 TAIWAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1294 TAIWAN: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1295 TAIWAN: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1296 TAIWAN: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1297 TAIWAN: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1298 TAIWAN: ENDOPROSTHESIS MARKET, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1299 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1300 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1301 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1302 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1303 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1304 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1305 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1306 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1307 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1308 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1309 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1310 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1311 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1312 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1313 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1314 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1315 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1316 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1317 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1318 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1319 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1320 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1321 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1322 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1323 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1324 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1325 NEW ZEALAND: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1326 NEW ZEALAND: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1327 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)

TABLE 1328 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)

TABLE 1329 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1330 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1331 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1332 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1333 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1334 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1335 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1336 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT 2022-2030 (USD MILLION)

TABLE 1337 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1338 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)

TABLE 1339 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)

TABLE 1340 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1341 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)

TABLE 1342 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1343 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1344 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)

TABLE 1345 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)

TABLE 1346 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1347 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)

TABLE 1348 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)

TABLE 1349 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1350 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)

TABLE 1351 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)

TABLE 1352 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)

TABLE 1353 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)

TABLE 1354 REST OF ASIA-PACIFIC: ENDOPROSTHESIS MARKET, FOR ANKLE/FOOT, 2022-2030 (USD MILLION)

TABLE 1355 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET, BY REGION, 2022–2030 (USD MILLION)

TABLE 1356 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1357 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1358 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1359 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1360 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1361 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1362 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1363 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1364 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1365 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1366 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1367 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1368 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1369 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1370 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1371 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1372 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1373 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1374 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1375 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1376 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1377 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1378 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1379 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1380 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1381 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1382 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1383 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1384 SAUDI ARABIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1385 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1386 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1387 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1388 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1389 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1390 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1391 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1392 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1393 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1394 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1395 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1396 SAUDI ARABIA: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1397 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1398 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1399 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1400 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1401 SAUDI ARABIA ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1402 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1403 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1404 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1405 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1406 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1407 SAUDI ARABIA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1408 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1409 SAUDI ARABIA ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1410 SAUDI ARABIA: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1411 SAUDI ARABIA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1412 UAE: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1413 UAE: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1414 UAE: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1415 UAE: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1416 UAE: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1417 UAE: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1418 UAE: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1419 UAE: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1420 UAE: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1421 UAE: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1422 UAE: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1423 UAE: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1424 UAE: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1425 UAE: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1426 UAE: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1427 UAE: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1428 UAE: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1429 UAE ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1430 UAE: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1431 UAE: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1432 UAE: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1433 UAE: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1434 UAE: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1435 UAE: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1436 UAE: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1437 UAE ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1438 UAE: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1439 UAE: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1440 EGYPT: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1441 EGYPT: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1442 EGYPT: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1443 EGYPT: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1444 EGYPT: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1445 EGYPT: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1446 EGYPT: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1447 EGYPT: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1448 EGYPT: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1449 EGYPT: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1450 EGYPT: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1451 EGYPT: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1452 EGYPT: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1453 EGYPT: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1454 EGYPT: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1455 EGYPT: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1456 EGYPT: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1457 EGYPT ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1458 EGYPT: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1459 EGYPT: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1460 EGYPT: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1461 EGYPT: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1462 EGYPT: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1463 EGYPT: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1464 EGYPT: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1465 EGYPT ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1466 EGYPT: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1467 EGYPT: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1468 ISRAEL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1469 ISRAEL: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1470 ISRAEL: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1471 ISRAEL: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1472 ISRAEL: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1473 ISRAEL: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1474 ISRAEL: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1475 ISRAEL: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1476 ISRAEL: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1477 ISRAEL: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1478 ISRAEL: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1479 ISRAEL: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1480 ISRAEL: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1481 ISRAEL: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1482 ISRAEL: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1483 ISRAEL: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1484 ISRAEL: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1485 ISRAEL ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1486 ISRAEL: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1487 ISRAEL: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1488 ISRAEL: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1489 ISRAEL: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1490 ISRAEL: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1491 ISRAEL: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1492 ISRAEL: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1493 ISRAEL ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1494 ISRAEL: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1495 ISRAEL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1496 SOUTH AFRICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1497 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1498 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1499 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1500 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1501 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1502 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1503 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1504 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1505 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1506 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1507 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1508 SOUTH AFRICA: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1509 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1510 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1511 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1512 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1513 SOUTH AFRICA ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1514 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1515 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1516 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1517 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1518 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1519 SOUTH AFRICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1520 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1521 SOUTH AFRICA ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1522 SOUTH AFRICA: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1523 SOUTH AFRICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1524 SYRIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1525 SYRIA: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1526 SYRIA: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1527 SYRIA: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1528 SYRIA: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1529 SYRIA: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1530 SYRIA: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1531 SYRIA: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1532 SYRIA: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1533 SYRIA: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1534 SYRIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1535 SYRIA: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1536 SYRIA: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1537 SYRIA: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1538 SYRIA: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1539 SYRIA: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1540 SYRIA: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1541 SYRIA ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1542 SYRIA: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1543 SYRIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1544 SYRIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1545 SYRIA: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1546 SYRIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1547 SYRIA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1548 SYRIA: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1549 SYRIA ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1550 SYRIA: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1551 SYRIA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1552 REST OF MEA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1553 REST OF MEA: ENDOPROSTHESIS MARKET FOR KNEE, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 1554 REST OF MEA: ENDOPROSTHESIS MARKET FOR PRIMARY KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1555 REST OF MEA: ENDOPROSTHESIS MARKET FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1556 REST OF MEA: ENDOPROSTHESIS MARKET FOR FIXED-BEARING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1557 REST OF MEA: ENDOPROSTHESIS MARKET FOR CRUCIATE-RETAINING, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1558 REST OF MEA: ENDOPROSTHESIS MARKET FOR PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1559 REST OF MEA: ENDOPROSTHESIS MARKET FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1560 REST OF MEA: ENDOPROSTHESIS MARKET FOR REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1561 REST OF MEA: ENDOPROSTHESIS MARKET FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1562 REST OF MEA: ENDOPROSTHESIS MARKET FOR TUMOR, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1563 REST OF MEA: ENDOPROSTHESIS MARKET FOR CUSTOM MADE REPLACEMENTS, BY KNEE, 2022–2030 (USD MILLION)

TABLE 1564 REST OF MEA: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)

TABLE 1565 REST OF MEA: ENDOPROSTHESIS MARKET FOR PRIMARY HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1566 REST OF MEA: ENDOPROSTHESIS MARKET FOR PRIMARY HYBRID HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1567 REST OF MEA: ENDOPROSTHESIS MARKET FOR PARTIAL HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1568 REST OF MEA: ENDOPROSTHESIS MARKET FOR REVISION HIP REPLACEMENT, BY HIP, 2022–2030 (USD MILLION)

TABLE 1569 REST OF MEA ENDOPROSTHESIS MARKET FOR COMPLETE HIP REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1570 REST OF MEA: ENDOPROSTHESIS MARKET FOR ACETABULAR COMPONENT REVISION, BY HIP, 2022–2030 (USD MILLION)

TABLE 1571 REST OF MEA: ENDOPROSTHESIS MARKET FOR TUMOR, BY HIP, 2022–2030 (USD MILLION)

TABLE 1572 REST OF MEA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1573 REST OF MEA: ENDOPROSTHESIS MARKET FOR PRIMARY SHOULDER REPLACEMENT, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1574 REST OF MEA: ENDOPROSTHESIS MARKET FOR TUMOR, BY SHOULDER, 2022–2030 (USD MILLION)

TABLE 1575 REST OF MEA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1576 REST OF MEA: ENDOPROSTHESIS MARKET FOR TUMOR, BY ELBOW, 2022–2030 (USD MILLION)

TABLE 1577 REST OF MEA ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1578 REST OF MEA: ENDOPROSTHESIS MARKET FOR MCP FINGER PROSTHESIS, BY FINGER/HAND, 2022–2030 (USD MILLION)

TABLE 1579 REST OF MEA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)

TABLE 1580 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

TABLE 1581 THE MOST ACTIVE PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

TABLE 1582 NEW PRODUCT DEVELOPMENTS/LAUNCHES

TABLE 1583 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/JOINT VENTURES

TABLE 1584 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES OFFERED

TABLE 1585 JOHNSON & JOHNSON SERVICES, INC.: KEY DEVELOPMENTS

TABLE 1586 ZIMMER BIOMET HOLDINGS INC.: PRODUCTS/SERVICES OFFERED

TABLE 1587 ZIMMER BIOMET HOLDINGS INC.: KEY DEVELOPMENTS

TABLE 1588 STRYKER: PRODUCTS/SERVICES OFFERED

TABLE 1589 STRYKER: KEY DEVELOPMENTS

TABLE 1590 SMITH AND NEPHEW: PRODUCTS/SERVICES OFFERED

TABLE 1591 SMITH AND NEPHEW: KEY DEVELOPMENTS

TABLE 1592 WALDEMAR LINK GMBH & CO. KG: PRODUCTS/SERVICES OFFERED

TABLE 1593 LIMACORPORATE SPA: PRODUCTS/SERVICES OFFERED

TABLE 1594 LIMACORPORATE SPA: KEY DEVELOPMENTS

TABLE 1595 CORIN LTD: PRODUCTS OFFERED

TABLE 1596 CORIN LTD: KEY DEVELOPMENTS

TABLE 1597 PETER BREHM GMBH: PRODUCTS OFFERED

TABLE 1598 MATHYS LTD BETTLACH: PRODUCTS OFFERED

TABLE 1599 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED

TABLE 1600 MEDACTA INTERNATIONAL SA: PRODUCTS/SERVICES OFFERED

TABLE 1601 MEDACTA INTERNATIONAL SA: KEY DEVELOPMENTS

TABLE 1602 EXACTECH, INC.: PRODUCTS OFFERED

TABLE 1603 MEDACTA INTERNATIONAL SA: KEY DEVELOPMENTS

TABLE 1604 MICROPORT ORTHOPEDICS, INC.: PRODUCTS OFFERED

TABLE 1605 MICROPORT ORTHOPEDICS, INC.: KEY DEVELOPMENTS

TABLE 1606 TIPSAN: PRODUCTS OFFERED

TABLE 1607 BAUMER SA: PRODUCTS OFFERED

TABLE 1608 IMPOL: PRODUCTS OFFERED

TABLE 1609 GROUPE LEPINE: PRODUCTS OFFERED

TABLE 1610 CONFORMIS: PRODUCTS OFFERED

TABLE 1611 CONFORMIS.: KEY DEVELOPMENTS

TABLE 1612 DJO: PRODUCTS OFFERED

TABLE 1613 DJO GLOBAL.: KEY DEVELOPMENTS

TABLE 1614 IMPLANTCAST: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 ENDOPROSTHESIS MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ENDOPROSTHESIS MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 VALUE CHAIN ANALYSIS: ENDOPROSTHESIS MARKET

FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: ENDOPROSTHESIS MARKET

FIGURE 8 GLOBAL ENDOPROSTHESIS MARKET, BY PRODUCT, 2020 & 2030 (USD MILLION)

FIGURE 9 GLOBAL ENDOPROSTHESIS MARKET, BY KNEE, 2020 & 2030 (USD MILLION)

FIGURE 10 GLOBAL ENDOPROSTHESIS MARKET, BY HIP, 2020 & 2030 (USD MILLION)

FIGURE 11 GLOBAL ENDOPROSTHESIS MARKET, BY SHOULDER TYPE, 2020 & 2030 (USD MILLION)

FIGURE 12 GLOBAL ENDOPROSTHESIS MARKET, BY ELBOW TYPE, 2020 & 2030 (USD MILLION)

FIGURE 13 GLOBAL ENDOPROSTHESIS MARKET, BY FINGER/HAND TYPE, 2020 & 2030 (USD MILLION)

FIGURE 14 GLOBAL ENDOPROSTHESIS MARKET, BY ANKLE/FOOT TYPE, 2020 & 2030 (USD MILLION)

FIGURE 15 GLOBAL: ENDOPROSTHESIS MARKET, BY REGION 2020 & 2030 (USD MILLION)

FIGURE 16 GLOBAL: ENDOPROSTHESIS MARKET SHARE, BY REGION 2020 (%)

FIGURE 17 NORTH AMERICA: ENDOPROSTHESIS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 18 SOUTH AMERICA ENDOPROSTHESIS MARKET, BY REGION, 2020 (%)

FIGURE 19 EUROPE: ENDOPROSTHESIS MARKET, BY COUNTRY, 2020 (%)

FIGURE 20 ASIA-PACIFIC ENDOPROSTHESIS MARKET, BY REGION, 2020 (%)

FIGURE 21 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET SHARE, BY REGION 2020 (%)

FIGURE 22 THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 24 GLOBAL ENDOPROSTHESIS MARKET: COMPETITIVE LANDSCAPE

FIGURE 25 REVENUE OF MAJOR PLAYERS, 2020

FIGURE 26 MAJOR PLAYERS R&D EXPENDITURE, 2020

FIGURE 27 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ZIMMER BIOMET HOLDINGS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ZIMMER BIOMET HOLDINGS INC.: SWOT ANALYSIS

FIGURE 31 STRYKER: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 STRYKER: SWOT ANALYSIS

FIGURE 33 SMITH AND NEPHEW: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 SMITH AND NEPHEW: SWOT ANALYSIS

FIGURE 35 WALDEMAR LINK GMBH & CO. KG: SWOT ANALYSIS

FIGURE 36 LIMACORPORATE SPA: SWOT ANALYSIS

FIGURE 37 CORIN LTD: SWOT ANALYSIS

FIGURE 38 PETER BREHM GMBH: SWOT ANALYSIS

FIGURE 39 MATHYS LTD BETTLACH: SWOT ANALYSIS

FIGURE 40 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS

FIGURE 42 MEDACTA INTERNATIONAL SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 43 MEDACTA INTERNATIONAL SA: SWOT ANALYSIS

FIGURE 44 EXACTECH, INC.: SWOT ANALYSIS

FIGURE 45 MICROPORT ORTHOPEDICS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 46 MICROPORT ORTHOPEDICS, INC.: SWOT ANALYSIS

FIGURE 47 TIPSAN: SWOT ANALYSIS

FIGURE 48 BAUMER S.A.: SWOT ANALYSIS

FIGURE 49 IMPOL: SWOT ANALYSIS

FIGURE 50 GROUPE LEPINE: SWOT ANALYSIS

FIGURE 51 CONFORMIS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 52 CONFORMIS: SWOT ANALYSIS

FIGURE 53 DJO: SWOT ANALYSIS

FIGURE 54 IMPLANTCAST: SWOT ANALYSIS

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Why Choose Market Research Future?

Leading companies partner with us for data-driven Insights